ALK – Financial calendar for the 2025 financial year

GlobeNewswire12-21 00:09

2025 financial calendar for ALK (ALKB:DC / OMX: ALK B / AKBLF):

22 January 2025: Silent period
19 February 2025: Annual report 2024
13 March 2025 at 4.00 p.m.: Annual General Meeting

to be held at ALK
Bøge Allé 1
2970 Hørsholm, Denmark

Written requests to have specific business
transacted at the AGM will be included in the
agenda if received by the company on
29 January 2025 at the latest
(may be emailed to investor@alk.net)

8 April 2025: Silent period
6 May 2025: Three-month interim report (Q1) 2025
24 July 2025: Silent period
21 August 2025: Six-month interim report (Q2) 2025
16 October 2025: Silent period
13 November 2025: Nine-month interim report (Q3) 2025

ALK-Abelló A/S

For further information please contact:

Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525

Media: Maiken Riise Andersen, tel. +45 5054 1434

About ALK
ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,900 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net.

Attachment

InvestorNews_20Dec24_FinancialCalendar

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2493042364?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-21 00:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2493042364","market":"us","top_or_hot":-1,"title":"ALK – Financial calendar for the 2025 financial year","media":"GlobeNewswire","content":"<html><body><p>2025 financial calendar for ALK (<i>ALKB:DC / OMX: ALK B / AKBLF</i>):</p> <ul><li>22 January 2025:                      Silent period                        </li><li>19 February 2025:                    Annual report 2024              </li><li>13 March 2025 at 4.00 p.m.:     Annual General Meeting</li></ul> <p>to be held at ALK<br/> Bøge Allé 1<br/> 2970 Hørsholm, Denmark <br/> <br/> Written requests to have specific business <br/> transacted at the AGM will be included in the<br/> agenda if received by the company on<br/> 29 January 2025 at the latest<br/> (may be emailed to investor@alk.net)<br/> <br/> </p> <ul><li>8 April 2025:                             Silent period                        </li><li>6 May 2025:                             Three-month interim report (Q1) 2025              </li><li>24 July 2025:                            Silent period                        </li><li>21 August 2025:                       Six-month interim report (Q2) 2025                  </li><li>16 October 2025:                      Silent period                        </li><li>13 November 2025:                  Nine-month interim report (Q3) 2025               </li></ul> <p><b>ALK-Abelló A/S</b></p> <p><b>For further information please contact:</b></p> <p><em>Investor Relations</em>: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525</p> <p><i>Media: </i>Maiken Riise Andersen, tel. +45 5054 1434</p> <p><b><i>About ALK</i></b><br/><i>ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,900 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net.</i></p> <p>\n<strong>Attachment</strong>\n</p>\n<ul>\n<li>\nInvestorNews_20Dec24_FinancialCalendar\n</li>\n</ul>\n<br/><img referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml-eu.globenewswire.com/media/NzIxY2RkYjYtOWExMi00OWUwLWJmMDItNjA2ZjNjZTcwMzY4LTEwMTM4MDQ=/tiny/ALK-Abello.png\"/></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ALK – Financial calendar for the 2025 financial year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nALK – Financial calendar for the 2025 financial year\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-21 00:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.globenewswire.com/news-release/2024/12/20/3000728/0/en/ALK-Financial-calendar-for-the-2025-financial-year.html><strong>GlobeNewswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2025 financial calendar for ALK (ALKB:DC / OMX: ALK B / AKBLF): 22 January 2025:                      Silent period                        19 February 2025:                    Annual report 2024      ...</p>\n\n<a href=\"https://www.globenewswire.com/news-release/2024/12/20/3000728/0/en/ALK-Financial-calendar-for-the-2025-financial-year.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4500","symbol_name":"航空公司","start_time":0,"source_url":"https://www.globenewswire.com/news-release/2024/12/20/3000728/0/en/ALK-Financial-calendar-for-the-2025-financial-year.html","article_id":"2493042364","we_media_id":"1016364462","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2493042364","pubTimestamp":1734710940,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"GlobeNewswire","introduction":"Share your news with media, investors, and consumers with targeted distribution options from one of the world’s largest and most trusted newswires.","home_visible":1,"id":"1016364462","head_image":"https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a"},"summary":"2025 financial calendar for ALK : 22 January 2025: Silent period 19 February 2025: Annual report 2024 13 March 2025 at 4.00 p.m.: Annual General Meeting to be held at ALK Bge Allé 1 2970 Hrsholm, Denmark   Written requests to have specific business  transacted at the AGM will be included in the agenda if received by the company on 29 January 2025 at the latest    8 April 2025: Silent period 6 May 2025:  Three-month interim report  2025  24 July 2025:  Silent period 21 August 2025:  Six-month interim report  2025  16 October 2025:  Silent period 13 November 2025:  Nine-month interim report  2025   ALK-Abelló A/S For further information please contact: Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525 Media: Maiken Riise Andersen, tel. +45 5054 1434 About ALKALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctor","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4500":"航空公司","ALK":"阿拉斯加航空集团有限公司","BK4585":"ETF&股票定投概念","BK4588":"碎股","BK4008":"航空公司"},"translate_title":"ALK–2025财年财务日历","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALK":1},"content_text":"2025 financial calendar for ALK (ALKB:DC / OMX: ALK B / AKBLF): 22 January 2025:                      Silent period                        19 February 2025:                    Annual report 2024              13 March 2025 at 4.00 p.m.:     Annual General Meeting to be held at ALK Bøge Allé 1 2970 Hørsholm, Denmark   Written requests to have specific business  transacted at the AGM will be included in the agenda if received by the company on 29 January 2025 at the latest (may be emailed to investor@alk.net)   8 April 2025:                             Silent period                        6 May 2025:                             Three-month interim report (Q1) 2025              24 July 2025:                            Silent period                        21 August 2025:                       Six-month interim report (Q2) 2025                  16 October 2025:                      Silent period                        13 November 2025:                  Nine-month interim report (Q3) 2025                ALK-Abelló A/S For further information please contact: Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525 Media: Maiken Riise Andersen, tel. +45 5054 1434 About ALKALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,900 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net. \nAttachment\n\n\n\nInvestorNews_20Dec24_FinancialCalendar","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2493042364"}